feed,title,long_url,short_url
Barron's,Iovance Stock Falls Almost 40% on Double Dose of Bad News,https://www.barrons.com/articles/iovance-stock-ceo-fda-cancer-delay-51621514716?mod=RTA,https://j.mp/3hAJUfM
